Recent evidences suggest that, in AML, Cyr61 mediated AML cell growth by the ERK1/2 pathway25; however, our findings showed that ERK1/2 did not contribute to Cyr61-induced ALL cell survival. This evidence concerns the gene MAPK3 and acute lymphoblastic leukemia.